Showing results (1101-1110 of 1,385) with videos related to

Sort By:
Pageof 139
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2020
Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychosesRéjane Troudet, Wafa Bel Haj Ali, Delphine Bacq-Daian, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2019
Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotypeMatthijs G Bossong, Hendrika H van Hell, Chris D Schubart, et al.
Clinical Epigenetics|April 8, 2024
Meta-analysis of epigenetic aging in schizophrenia reveals multifaceted relationships with age, sex, illness duration, and polygenic riskAnil P S Ori, Loes M Olde Loohuis, Jerry Guintivano, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
No association between 12 dopaminergic genes and schizophrenia in a large Dutch sampleMechteld L C Hoogendoorn, Steven C Bakker, Hugo G Schnack, et al.
Psychological Medicine|July 29, 2014
Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorderF Bootsman, R M Brouwer, H G Schnack, et al.
Schizophrenia Bulletin|May 25, 2016
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysisJian-Ping Zhang, Todd Lencz, Ryan X Zhang, et al.
Epigenomics|July 29, 2021
DNA methylation differences in cortical grey and white matter in schizophreniaAmber Berdenis van Berlekom, Nina Notman, Marjolein Am Sneeboer, et al.
Translational Psychiatry|May 26, 2019
Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activatedMarjolein A M Sneeboer, Gijsje J L J Snijders, Woutje M Berdowski, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 12, 2008
Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patientsSabine A Fuchs, Martina M J De Barse, Floor E Scheepers, et al.
Neuroimage|December 14, 2011
Genetic influences on thinning of the cerebral cortex during developmentI L C van Soelen, R M Brouwer, G C M van Baal, et al.
Pageof 139